Insights into the TERMIS-AM Conference in Boston, USA, April 11-14, 2023
The TERMIS-AM conference brings together leading scientists around the world every year to discuss the advancements in tissue engineering and regenerative medicine and to generate knowledge with a view to improve patient outcomes globally. This year, 2023, was an especially great year for the Brinter Team, as it was the first year showcasing our modular bioprinting technology to fellow scientists and joining this world-class network within North America.
Our team, consisting of CEO, Tom Alapaattikoski and application managers, Eva Mueller and Matthew Brovold, showcased our Brinter ONE 3D bioprinter, with live demos of 3D printing meniscus bio-implants, and we welcomed many engaging conversations around the 3D bioprinting technology and our in-house applications development.
“I am so impressed by the modularity of your bioprinting platform. Whether I am printing materials for a skin tissue application or bone in the future, the technology is capable of printing any material of choice, without sacrificing on the complexity of native tissues.”
A visitor to our booth stated.
“TERMIS-AM fostered many new relationships and connections in both academia and industry, and we look forward to keeping in touch with the wider TERMIS community. We are already looking forward to joining the TERMIS World Congress next year in Seattle!”
Tom Alapaattikoski, CEO, Brinter Inc